Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fein

Showing results (481-490 of 492) with videos related to

Pageof 50
Sort By:
Haematologica|November 21, 2024
Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapyAlexander P Boardman, Victoria Gutgarts, Jessica Flynn, et al.
JAMA Psychiatry|February 3, 2021
Prospective Development and Validation of the Computerized Adaptive Screen for Suicidal YouthCheryl A King, David Brent, Jacqueline Grupp-Phelan, et al.
JAMA Network Open|February 15, 2023
Prediction of Suicide Attempts and Suicide-Related Events Among Adolescents Seen in Emergency DepartmentsDavid A Brent, Lisa M Horowitz, Jacqueline Grupp-Phelan, et al.
Transplantation and Cellular Therapy|August 9, 2022
Vitamin D Insufficiency and Clinical Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Large B-cell LymphomaKarthik Nath, Ana Alarcon Tomas, Jessica Flynn, et al.
British Journal of Haematology|May 12, 2024
Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profileRoni Shouval, Adam Goldman, Jessica R Flynn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2021
Impact of <i>TP53</i> Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell TherapyRoni Shouval, Ana Alarcon Tomas, Joshua A Fein, et al.
The Lancet. Haematology|February 26, 2021
Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registryRoni Shouval, Joshua A Fein, Myriam Labopin, et al.
Frontiers in Immunology|April 17, 2024
Donor <i>KIR</i> genotype based outcome prediction after allogeneic stem cell transplantation: no land in sightJohannes Schetelig, Henning Baldauf, Falk Heidenreich, et al.
Blood Advances|June 12, 2025
Bone marrow and blood demonstrate distinct immune reconstitution patterns and correlations with relapse post-transplantSusan DeWolf, Jason Kuttiyara, Paola Vinci, et al.
Leukemia|November 6, 2022
Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphomaAna Alarcon Tomas, Joshua A Fein, Shalev Fried, et al.
Pageof 50

Showing results (481-490 of 492) with videos related to

Sort By:
Pageof 50
Haematologica|November 21, 2024
Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapyAlexander P Boardman, Victoria Gutgarts, Jessica Flynn, et al.
JAMA Psychiatry|February 3, 2021
Prospective Development and Validation of the Computerized Adaptive Screen for Suicidal YouthCheryl A King, David Brent, Jacqueline Grupp-Phelan, et al.
JAMA Network Open|February 15, 2023
Prediction of Suicide Attempts and Suicide-Related Events Among Adolescents Seen in Emergency DepartmentsDavid A Brent, Lisa M Horowitz, Jacqueline Grupp-Phelan, et al.
Transplantation and Cellular Therapy|August 9, 2022
Vitamin D Insufficiency and Clinical Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Large B-cell LymphomaKarthik Nath, Ana Alarcon Tomas, Jessica Flynn, et al.
British Journal of Haematology|May 12, 2024
Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profileRoni Shouval, Adam Goldman, Jessica R Flynn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2021
Impact of <i>TP53</i> Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell TherapyRoni Shouval, Ana Alarcon Tomas, Joshua A Fein, et al.
The Lancet. Haematology|February 26, 2021
Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registryRoni Shouval, Joshua A Fein, Myriam Labopin, et al.
Frontiers in Immunology|April 17, 2024
Donor <i>KIR</i> genotype based outcome prediction after allogeneic stem cell transplantation: no land in sightJohannes Schetelig, Henning Baldauf, Falk Heidenreich, et al.
Blood Advances|June 12, 2025
Bone marrow and blood demonstrate distinct immune reconstitution patterns and correlations with relapse post-transplantSusan DeWolf, Jason Kuttiyara, Paola Vinci, et al.
Leukemia|November 6, 2022
Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphomaAna Alarcon Tomas, Joshua A Fein, Shalev Fried, et al.
Pageof 50